Top Medical News
Pearl Toh, 15 hours ago
The trade-off between the risk of ischaemic vs bleeding events may be different between Asian and non-Asian patients, which warrants careful consideration when deciding on the duration of antiplatelet therapy following a percutaneous coronary intervention (PCI), according to a presentation at ESC Asia Congress 2019.
Elvira Manzano, 20 hours ago
Treatment with the SGLT2* inhibitor dapagliflozin appears to attenuate renal decline in patients with heart failure and reduced ejection fraction (HFrEF), regardless of whether they have CKD, according to a prespecified subanalysis of the landmark DAPA-HF trial presented at ASN Kidney Week 2019.
21 hours ago
The risk of acute coronary syndrome (ACS) is increased in individuals with idiopathic inflammatory myopathies (IIM), especially within the first year following diagnosis, according to a recent study.
Stephen Padilla, 22 hours ago
Mindfulness-based interventions (MBIs) help reduce depression and anxiety and improve health-related quality of life (HRQoL) in the short-term among patients with heart failure (HF), according to preliminary evidence of a systematic review.
Yesterday
Pregnant women with elevated blood pressure (BP) levels below the diagnostic criteria of hypertensive disorders of pregnancy (HDP) at 28 and 34 weeks of gestation are at high risk of developing stage 1 hypertension 5 years later, a study has found.
Elvira Manzano, Yesterday
Roxadustat improves haemoglobin levels vs placebo and epoetin alfa, with similar safety profile, in 8,000 patients with chronic kidney disease (CKD)-related anaemia on- and off-dialysis, according to a pooled efficacy and CV safety analyses of roxadustat, spanning over 13,000 patient exposure years.
Yesterday
Pregnancy does not appear to aggravate the risk of bleeding and venous thromboembolism (VTE) in women with Klippel-Trenaunay syndrome (KTS), a recent study has shown.
Special Reports
24 Sep 2019
Hypertension (HPT) is defined as a persistent elevation of systolic blood pressure (BP) of 140 mmHg or greater and/or diastolic BP of 90 mmHg or greater, taken at least twice ontwo separate occasions. The most recent National Health and Morbidity Survey (NHMS) 2015 that focuses on noncommunicable diseases showed that among adults aged 18 years and older, there was an increase in the prevalence of HPT from 33.6% in 2011 to 35.3%. While the proportion of patients with HPT who have attained good BP control has increased from 34.7% in 2011 to 37.4%, the awareness of the condition among patients remains poor. The prevalence of undiagnosed HPT remains high; hence, it is recommended that every adult aged 18 years and older to check their BP at least once annually, and more frequently in those with risk factors (eg, family history, obese).
11 Sep 2019
At the recent 10th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress(MAC) held in Hilton Kuala Lumpur, Dr Wong Ming, a consultant endocrinologist from Sunway Medical Centre, spoke on the role of non–high-density lipoprotein cholesterol (non–HDL-c) as an emerging marker and treatment target for cardiovascular (CV) disease. Additionally, she also highlighted the role of fenofibrate in delaying and preventing diabetic retinopathy (DR).
Prof. Rafael R. Castillo, Dr. Hyo Seung Ahn, 20 Aug 2019
Major trials have demonstrated the benefits of beta-blockers in the treatment of hypertension.1 At a recent symposium held during the Asian Pacific Society of Cardiology 2019 Congress in Manila, Philippines, experts discussed the latest guidelines on hypertension treatment, with a focus on the role of the 3rd generation beta-blocker, nebivolol. The symposium was chaired by Dr Dante D. Morales, Clinical Associate Professor at the University of the Philippines College of Medicine, and featured renowned cardiologists Prof Rafael R. Castillo and Dr Hyo Seung Ahn.
22 Jul 2019
Coenzyme Q10 (CoQ10, ubiquinone) is a fat-soluble, potent physiological antioxidant that is required for the production of cellular adenosine triphosphate (ATP). CoQ10 can be obtained through tissue synthesis and diet, and it has been widely studied in patients with cardiovascular (CV) risk factors. The effects of oral CoQ10 supplementation in different patient subgroups are presented here.
24 Apr 2019
At the recent 12th IDF-WPR Congress and 10th AASD Scientific Meeting held at Kuala Lumpur Convention Centre, the importance of glycaemic control and the practical management of type 2 diabetes mellitus (T2DM) were highlighted by two international speakers, Dr Sanjay Kalra from India and Professor Jean Claude Mbanya from Cameroon.
19 Apr 2019
At a webinar hosted by Pfizer, leading Malaysian family medicine specialists Professor Chia Yook Chin andProfessor Sherina Mohd Sidik discussed a host of issues commonly encountered in primary care, includingpreventing cardiovascular (CV) disease, pain control in osteoarthritis (OA) and depression management.
Dr. Choo Gim Hooi, Assoc Prof. Pattarapong Makarawate, Dr. Krisada Sastravaha, 17 Dec 2018
Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally and its burden is expected to increase due to the rising prevalence of risk factors such as hypertension, diabetes, and dyslipidaemia. In conjunction with the 23rd ASEAN Federation of Cardiology Congress held in Bangkok, Thailand, Menarini organized a lunch symposium and product theatre to discuss the significance of optimal medical therapy (OMT) in the management of stable CAD, with a focus on the role of ranolazine (Ranexa®).
Conference Reports
Pearl Toh, 20 Nov 2019
The trade-off between the risk of ischaemic vs bleeding events may be different between Asian and non-Asian patients, which warrants careful consideration when deciding on the duration of antiplatelet therapy following a percutaneous coronary intervention (PCI), according to a presentation at ESC Asia Congress 2019.
Audrey Abella, 18 Nov 2019
Several Asian studies evaluating different types of valvular heart disease (VHD) reflected poor clinical outcomes, according to a discussion during ESC Asia 2019.
18 Nov 2019
Podcast: Prof Carolyn Lam speaks on the challenges of managing HF in Asia
18 Nov 2019
Podcast: Prof Michel Komajda shares his insights on what the ESC hypertension guidelines mean for Asians
18 Nov 2019
Podcast: Assoc Prof Yeo Khung Keong talks about the hopes and promises of AI in cardiology
Pearl Toh, 15 Nov 2019
The prognosis and the optimal doses of guideline-directed medical therapy (GDMT) for heart failure (HF) appear to be different between men and women, according to leading cardiologist Professor Carolyn Lam from the Duke-National University of Singapore.
Jairia Dela Cruz, 15 Nov 2019
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.
Product Highlights
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download